New Delhi, Aug. 27 -- The Indian pharmaceutical industry has been exempted from immediate tariff increases in the US due to the significance of generic medications for providing affordable healthcare in the country. This decision comes after President Trump implemented a 25% tariff on India related to the purchase of Russian oil, bringing the overall tariff to 50%, which takes effect today, August 27.

According to Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, the Indian pharmaceutical industry has been "excluded" from the US's immediate tariff enforcement, as generic medications are "crucial" for maintaining affordable healthcare in the US, as reported by ANI.

The sector is currently under review as part of th...